Interferon-gamma Impairs Maintenance and Alters Hematopoietic Support of Bone Marrow Mesenchymal Stromal Cells.

Bone marrow (BM) mesenchymal stromal cells (MSCs) provide microenvironmental support to hematopoietic stem and progenitor cells (HSPCs). Culture-expanded MSCs are interesting candidates for cellular therapies due to their immunosuppressive and regenerative potential which can be further enhanced by pretreatment with interferon-gamma (IFN-). However, it remains unknown whether IFN- can also influence hematopoietic support by BM-MSCs. In this study, we elucidate the impact of IFN- on the hematopoietic support of BM-MSCs. We found that IFN- increases expression of interleukin (IL)-6 and stem cell factor by human BM-MSCs. IFN--treated BM-MSCs drive HSPCs toward myeloid commitment in vitro, but impair subsequent differentiation of HSPC. Moreover, IFN--ARE-Del mice with increased IFN- production specifically lose their BM-MSCs, which correlates with a loss of hematopoietic stem cells' quiescence. Although IFN- treatment enhances the immunomodulatory function of MSCs in a clinical setting, we conclude that IFN- negatively affects maintenance of BM-MSCs and their hematopoietic support in vitro and in vivo.